Advertisement

Blut

, Volume 48, Issue 1, pp 19–25 | Cite as

High dose gammaglobulin therapy in adults with idiopathic thrombocytopenic purpura (ITP) clinical effects

  • R. E. Schmidt
  • U. Budde
  • C. Bröschen-Zywietz
  • G. Schäfer
  • C. Mueller-Eckhardt
Original Articles

Summary

This study of the effect of high-dose intravenous gammaglobulins with one or two courses of therapy in 18 adults with idiopathic thrombocytopenia purpura showed a platelet rise in thirteen patients. The highest response rates were seen in splenectomized adults. In chronic patients the response was transient only. If therapy was effective, increased values of platelet-associated IgG were reduced, while shortened platelet survival times were prolonged. There was no influence of high-dose gammaglobulins on platelet function. Different 7S-preparations such as β-propiolactone modified Ig, pH 4 treated Ig and reduced and alkylated Ig have comparable effects.

Key words

High-dose gammaglobulin chronic idiopathic thrombocytopenic purpura platelet associated IgG 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abe T, Matsuda J, Kawasuki K, Yashimura Y, Kinoshita T, Kazama M (1983) Clinical effect of intravenous immunoglobulin on chronic idiopathic thrombocytopenic purpura. Blut 47: 69–75Google Scholar
  2. 2.
    Barandun S, Morell A (1981) Adverse reactions to immunoglobulin preparations. In: Nydegger UE (ed) Immunohemotherapy. Academic Press, London New York Toronto Sydney San FranciscoGoogle Scholar
  3. 3.
    Bierling P, Farcet JP, Duedari N, Rochant H (1982) Increased platelet-associated IgG in patient on high-dose gammaglobulin for autoimmune thrombocytopenic purpura. Lancet 2: 308Google Scholar
  4. 4.
    Borchgrevink EF, Waaler BA (1958) The secondary bleeding time: A new method for the differentiation of hemorrhagic diseases. Acta Med Scand 162: 361Google Scholar
  5. 5.
    Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927Google Scholar
  6. 6.
    Breddin K (1968) Die Thrombozytenfunktion bei hämorrhagischen Diathesen, Thrombosen und Gefäßkrankheiten, Schattauer, StuttgartGoogle Scholar
  7. 7.
    Budde U, Schmidt RE, Schäfer G (1983) Alteration of immune and particle clearance after treatment of idiopathic thrombocytopenic purpura with high dose intravenous gammaglobulin (abstract). Thromb Haemost 50: 317Google Scholar
  8. 8.
    Expert, Panel (1977) Recommended methods for radioisotope platelet survival studies. Blood 50: 1137Google Scholar
  9. 9.
    Faradji A, Lang JM, Boilletot A, Giron C, Bergerat JP, Schmitthäusler R, Zorn JJ, Hauptmann G, Mayer S, Oberling F (1982) Purpura thrombocytopénique idiopathique. Traitement par transfusion d'immunoglobulines polyvalentes intraveineuses. Nouv Presse Med 11: 3107Google Scholar
  10. 10.
    Fehr J, Hofmann V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. New Engl J Med 306: 1254Google Scholar
  11. 11.
    Howard WA, Firkin GB (1971) Ristocetin — a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 26: 362Google Scholar
  12. 12.
    Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228Google Scholar
  13. 13.
    Kind C, Morf P, Schneider H, Morell A (1982) Idiopathische thrombozytopenische Purpura in der Schwangerschaft. Schweiz Med Wochenschr 112: 1389Google Scholar
  14. 14.
    McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. New Engl J Med 304: 1135Google Scholar
  15. 15.
    Mueller-Eckhardt C, Mahn I, Schulz G, Mueller-Eckhardt G (1978) Detection of platelet autoantibodies by radioactive anti-immunoglobulin test. Vox Sang 35: 357Google Scholar
  16. 16.
    Mueller-Eckhardt C, Küenzlen E, Thilo-Körner D, Pralle H (1983) High-dose intravenous immunoglobulin for posttransfusion purpura. New Engl J Med 308: 287Google Scholar
  17. 17.
    Newland AC, Minchinton RM, Treleaven J, Berney S, Waters AH (1983) High-dose intravenous IgG in adult idiopathic thrombocytopenic purpura. Lancet 1: 84Google Scholar
  18. 18.
    Pollack S, Cunningham-Rundles C, Smithwich EM, Barandun S, Good RA (1982) High-dose intravenous gammaglobulin for auto-immune neutropenia. New Engl J Med 307: 253Google Scholar
  19. 19.
    Schmidt B, Förster J (1982) Increased platelet associated IgG in a child on high-dose gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 2: 39Google Scholar
  20. 20.
    Schmidt RE, Budde U, Schäfer G, Stroehmann I (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. Lancet 2: 475Google Scholar
  21. 21.
    Stuart MJ, Murphy S, Oski FA (1977) Simple, sensitive fluorimetric assay for malondialdehyde production by blood platelets. Thromb Res 11: 425Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • R. E. Schmidt
    • 1
    • 3
  • U. Budde
    • 2
    • 3
  • C. Bröschen-Zywietz
    • 1
    • 3
  • G. Schäfer
    • 2
    • 3
  • C. Mueller-Eckhardt
    • 2
    • 3
  1. 1.Medizinische Universitätsklinik BonnBonnFederal Republic of Germany
  2. 2.Institut für Experimentelle Hämatologie und BluttransfusionswesenBonnFederal Republic of Germany
  3. 3.Institut für Klinische Immunologie und Transfusionsmedizin, GießenGießenFederal Republic of Germany

Personalised recommendations